Home » Stocks » Apyx Medical

Apyx Medical Corporation (APYX)

Stock Price: $5.14 USD -0.08 (-1.53%)
Updated Aug 13, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 175.87M
Revenue (ttm) 25.25M
Net Income (ttm) -16.76M
Shares Out 34.22M
EPS (ttm) -0.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 13, 2020
Last Price $5.14
Previous Close $5.22
Change ($) -0.08
Change (%) -1.53%
Day's Open 5.21
Day's Range 5.11 - 5.28
Day's Volume 34,106
52-Week Range 2.81 - 8.59

More Stats

Market Cap 175.87M
Enterprise Value 130.83M
Earnings Date (est) Oct 29, 2020
Ex-Dividend Date n/a
Shares Outstanding 34.22M
Float 23.38M
EPS (basic) -0.5
EPS (diluted) -0.48
FCF / Share -0.62
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 567,326
Short Ratio 8.17
Short % of Float 2.02%
Beta 0.71
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 6.97
PB Ratio 2.66
Revenue 25.25M
Operating Income -24.29M
Net Income -16.76M
Free Cash Flow -21.33M
Net Cash 45.05M
Net Cash / Share 1.32
Gross Margin 75.62%
Operating Margin -96.20%
Profit Margin -66.20%
FCF Margin -84.48%
ROA -18.28%
ROE -22.31%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

(60.51% upside)
Current: $5.14
Target: 8.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth70.04%62.25%16.04%-70.13%6.64%16.99%-14.5%8.89%4.87%-
Gross Profit19.0910.836.965.1212.568.999.2011.3310.739.99
Operating Income-20.87-14.28-13.89-11.39-6.99-5.85-3.671.05-0.02-2.75
Net Income-19.7162.72-5.06-3.958.59-17.28-4.340.620.11-1.54
Shares Outstanding34.0733.1931.4227.4324.3317.7617.6717.6317.6017.37
Earnings Per Share-0.581.83-0.17-0.140.24-1.03-0.400.030.01-0.09
EPS Growth-------200%--
Operating Cash Flow-18.48-20.88-3.70-2.84-5.79-0.42-2.540.171.90-0.53
Capital Expenditures-1.30-0.36-0.62-0.29-0.42-0.63-0.59-0.75-0.540.43
Free Cash Flow-19.78-21.24-4.33-3.12-6.21-1.05-3.12-0.591.36-0.09
Cash & Equivalents58.8178.3510.7615.3412.776.637.924.164.883.83
Total Debt1.130.142.833.073.313.413.263.423.553.85
Net Cash / Debt57.6878.217.9312.279.453.224.670.741.33-0.03
Book Value71.2687.1822.0326.2223.401.5019.0722.9022.1221.77
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Apyx Medical Corporation
Country United States
Employees 266
CEO Charles D. Goodwin

Stock Information

Ticker Symbol APYX
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: APYX
IPO Date January 1, 1987


Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.